TNO155 |
| Catalog No.GC39514 |
TNO155 est un puissant inhibiteur allostérique sélectif et actif par voie orale de SHP2 de type sauvage (IC50=0,011 μM). TNO155 a le potentiel pour l'étude des tumeurs malignes dépendantes de RTK, en particulier les tumeurs solides avancées.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1801765-04-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
TNO155 is a potent selective and orally active allosteric inhibitor of wild-type SHP2 (IC50=0.011 µM). TNO155 has the potential for the study of RTK-dependent malignancies, especially advanced solid tumors[1].
[1]. TNO155: SHP2 inhibitor
Average Rating: 5 (Based on Reviews and 24 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *